Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
8.87
+0.15 (1.72%)
Sep 22, 2026, 4:00 PM EDT - Market closed
Immatics Market Cap
Immatics has a market cap or net worth of $1.21 billion as of September 22, 2026. Its market cap has increased by 48.87% in one year.
Market Cap
1.21B
Enterprise Value
779.74M
1-Year Change
48.87%
Ranking
Category
Stock Price
$8.87
ChartMarket Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.21B, an increase of 602.86%. That is a compound annual growth rate of 28.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 1.21B | -13.87% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 1.27B |
| Vor Biopharma | 1.27B |
| Maze Therapeutics | 1.25B |
| Replimune Group | 1.23B |
| Aktis Oncology | 1.22B |
| Apnimed | 1.21B |
| Alto Neuroscience | 1.19B |
| Odyssey Therapeutics | 1.17B |